ZEUS System vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies, Inc.
VS
by Verily

AI Verdict

The ZEUS System is an AI-powered software specifically designed for long-term continuous cardiac monitoring to detect and characterize arrhythmias for clinical management. In contrast, the Verily Study Watch is a multi-sensor wearable device primarily intended for continuous physiological data collection in clinical research, including ECG and irregular pulse monitoring. While both leverage wearable technology and cloud-based AI for cardiac insights, ZEUS focuses on direct clinical arrhythmia diagnosis, whereas Study Watch serves broader research applications.

Choose ZEUS System if…

Choose ZEUS System if your primary goal is to leverage AI-powered analytics for the clinical detection and characterization of cardiac arrhythmias, such as Atrial Fibrillation, in individual patients. This tool is ideal for healthcare providers seeking continuous ECG monitoring (up to 14 days) with preliminary report generation to aid in diagnosis and treatment planning.

View ZEUS System →

Choose Study Watch if…

Choose Verily Study Watch if your focus is on conducting rigorous clinical research studies requiring multi-modal, continuous physiological data collection from a wearable device. This prescription-only tool is best suited for researchers needing to gather comprehensive data, including ECG, heart rate, and movement, for in-depth analysis and discovery within a research context.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ZEUS System Study Watch
Pricing Not disclosed Unknown
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware. The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System

The ZEUS System emphasizes preliminary report generation for physicians and HL7-based EHR integration, streamlining clinical workflows. It integrates with iRhythm's Zio monitors, which are designed for patient simplicity in continuous cardiac monitoring. In contrast, the Study Watch is prescription-only and primarily for clinical research, suggesting a more involved setup for patients and less direct integration into routine clinical diagnostic workflows for physicians.

Clinical Value

ZEUS System

The ZEUS System is explicitly designed to aid in the detection and characterization of arrhythmias like Atrial Fibrillation, providing preliminary reports for physicians to support diagnosis and management. While the Study Watch collects ECG data and has an irregular pulse monitor with FDA clearance for AFib detection, its primary stated purpose is for clinical research and accelerating research, making its direct clinical diagnostic utility in routine practice less prominent than Tool A.

Pricing & Value

Tie

Both the ZEUS System and the Verily Study Watch have undisclosed pricing, making it impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition based on the available information.

Enterprise Readiness

ZEUS System

Both tools are FDA cleared, HIPAA compliant, and utilize cloud deployment. However, Tool B (Study Watch) has an ongoing lawsuit alleging HIPAA and BAA violations, which, even if denied, introduces a potential risk for enterprise adoption. Tool A (ZEUS System) explicitly mentions HL7-based EHR integration, a crucial feature for enterprise readiness in healthcare.

Innovation

Study Watch

While both tools are innovative in their use of AI and wearables for continuous monitoring, the Study Watch integrates multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements) for broader physiological monitoring in clinical research. This multi-modal data collection for expansive research purposes suggests a more foundational and potentially far-reaching innovation for future health insights beyond just cardiac arrhythmias.

Support & Docs

ZEUS System

The ZEUS System, as part of iRhythm's Zio Service, provides comprehensive and publicly accessible support and documentation for clinicians and patients, including detailed Instructions for Use (IFUs) and FAQs in multiple languages. Verily's Study Watch support and documentation appear more tailored to specific clinical research protocols and partnerships, with resources like Data Workbench and Site CTMS.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ZEUS System Study Watch
Primary Function AI-powered software analyzing ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Company iRhythm Technologies Verily Life Sciences
AI-powered Yes (AI-powered arrhythmia detection) Yes (Cloud-based data processing with algorithms and machine learning)
Key Data Collected/Monitored ECG data (for arrhythmia detection and characterization, Atrial Fibrillation). ECG, heart rate, electrodermal activity, inertial movements.
Continuous Monitoring Duration Up to 14 days Up to one week
EHR Integration HL7-based EHR integration Not specified

Videos

Demos, reviews, and walkthroughs featuring ZEUS System and Study Watch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ZEUS System is an AI-powered software designed for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. The Verily Study Watch is a prescription-only wearable device primarily for non-invasive, continuous physiological monitoring in clinical research.
The ZEUS System offers continuous ECG monitoring for up to 14 days, focusing on arrhythmia detection. The Study Watch provides continuous physiological monitoring, including ECG, heart rate, electrodermal activity, and inertial movements, with a battery life of up to one week.
The ZEUS System explicitly supports HL7-based EHR integration. The Study Watch's description focuses on data upload from the device to Verily's cloud platform for analysis, without specific mention of EHR integration for clinical practice.
The ZEUS System provides AI-powered arrhythmia detection, characterization of Atrial Fibrillation, and preliminary report generation for physicians. The Study Watch processes collected data in Verily's cloud platform using algorithms and machine learning, offering features like on-demand single-channel ECG and an irregular pulse monitor.
The ZEUS System is designed for use in Cardiology, Family Medicine, and Internal Medicine. The Verily Study Watch targets Cardiology, Neurology, and Sleep Medicine.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.